- Home
- GHRS vs AVAH Comparison
GHRS vs AVAH Comparison
Compare GHRS & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- AVAH
- Stock Information
- Founded
- GHRS 2018
- AVAH 1984
- Country
- GHRS Ireland
- AVAH United States
- Employees
- GHRS N/A
- AVAH N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- AVAH Hospital/Nursing Management
- Sector
- GHRS Health Care
- AVAH Health Care
- Exchange
- GHRS Nasdaq
- AVAH Nasdaq
- Market Cap
- GHRS 868.7M
- AVAH 972.5M
- IPO Year
- GHRS 2021
- AVAH 2021
- Fundamental
- Price
- GHRS $9.10
- AVAH $4.54
- Analyst Decision
- GHRS Strong Buy
- AVAH Hold
- Analyst Count
- GHRS 7
- AVAH 4
- Target Price
- GHRS $30.86
- AVAH $5.00
- AVG Volume (30 Days)
- GHRS 208.9K
- AVAH 288.0K
- Earning Date
- GHRS 05-02-2025
- AVAH 05-08-2025
- Dividend Yield
- GHRS N/A
- AVAH N/A
- EPS Growth
- GHRS N/A
- AVAH N/A
- EPS
- GHRS N/A
- AVAH N/A
- Revenue
- GHRS N/A
- AVAH $2,024,506,000.00
- Revenue This Year
- GHRS N/A
- AVAH $6.64
- Revenue Next Year
- GHRS N/A
- AVAH $5.00
- P/E Ratio
- GHRS N/A
- AVAH N/A
- Revenue Growth
- GHRS N/A
- AVAH 6.82
- 52 Week Low
- GHRS $6.00
- AVAH $2.11
- 52 Week High
- GHRS $20.50
- AVAH $6.19
- Technical
- Relative Strength Index (RSI)
- GHRS 39.47
- AVAH 41.37
- Support Level
- GHRS $8.51
- AVAH $4.61
- Resistance Level
- GHRS $9.36
- AVAH $4.92
- Average True Range (ATR)
- GHRS 0.79
- AVAH 0.36
- MACD
- GHRS -0.11
- AVAH -0.10
- Stochastic Oscillator
- GHRS 33.94
- AVAH 6.51
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.